Sorry, this section is only available in Japanese.

前のページに戻るこの文献は全文を取り寄せることができます

JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。

既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方

JDreamⅢ複写サービス
文献複写のお申込み

JDreamⅢ複写サービスのご利用が初めての方

学術文献の全文複写をお取寄せ
JDreamⅢ複写サービスのご案内

取り寄せる文献のタイトルと詳細

文献

J-GLOBAL ID：202002275085565841 整理番号：20A0795880

新たに診断された血管内大細胞型B細胞リンパ腫(PRIMEUR-IVL)に対する高用量メトトレキサート+髄腔内化学療法と併用したリツキシマブ,シクロホスファミド,ドキソルビシン,ビンクリスチンおよびプレドニゾロン:多施設,単腕,第2相試験【JST・京大機械翻訳】

Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial

著者 (35件)：

Shimada Kazuyuki

(Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan)

Yamaguchi Motoko

(Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan)

Atsuta Yoshiko

(Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan)

Matsue Kosei

(Division of Hematology/Oncology, Internal Medicine, Kameda Medical Center, Kamogawa, Japan)

Sato Keijiro

(Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan)

Kusumoto Shigeru

(Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan)

Nagai Hirokazu

(Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan)

Takizawa Jun

(Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan)

Fukuhara Noriko

(Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan)

Nagafuji Koji

(Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan)

Miyazaki Kana

(Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan)

Ohtsuka Eiichi

(Department of Hematology, Oita Prefectural Hospital, Oita, Japan)

Okamoto Masataka

(Department of Hematology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan)

Sugita Yasumasa

(Department of Hematology, Oami Municipal Hospital, Oamishirasato, Japan)

Uchida Toshiki

(Department of Hematology and Oncology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan)

Kayukawa Satoshi

(Department of Clinical Oncology, Nagoya Memorial Hospital, Nagoya, Japan)

Wake Atsushi

(Department of Hematology, Toranomon Hospital Kajigaya, Kawasaki, Japan)

Ennishi Daisuke

(Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan)

Kondo Yukio

(Department of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Japan)

Izumi Tohru

(Division of Hematology, Tochigi Cancer Center, Utsunomiya, Japan)

Kin Yoshihiro

(Department of Hematology, Daini Osaka Police Hospital, Osaka, Japan)

Tsukasaki Kunihiro

(Department of Hematology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan)

Hashimoto Daigo

(Department of Hematology, Hokkaido University Faculty of Medicine, Graduate School of Medicine, Sapporo, Japan)

Yuge Masaaki

(Division of Hematology, Ichinomiya Municipal Hospital, Ichinomiya, Japan)

Yanagisawa Atsumi

(Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan)

Kuwatsuka Yachiyo

(Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan)

Kuwatsuka Yachiyo

(Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan)

Shimada Satoko

(Department of Pathology and Clinical Laboratories, Nagoya University Hospital, Nagoya, Japan)

Masaki Yasufumi

(Department of Hematology and Immunology, Kanazawa Medical University, Uchinada, Japan)

Niitsu Nozomi

(International Medical Center, Saitama Medical University, Hidaka, Japan)

Kiyoi Hitoshi

(Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan)

Suzuki Ritsuro

(Department of HSCT Data Management and Biostatistics, Nagoya University School of Medicine, Nagoya, Japan)

Tokunaga Takashi

(Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan)

Nakamura Shigeo

(Department of Pathology and Clinical Laboratories, Nagoya University Hospital, Nagoya, Japan)

Kinoshita Tomohiro

(Division of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan)

資料名：

Lancet Oncology (Lancet Oncology)

巻： 21 号： 4 ページ： 593-602 発行年： 2020年
JST資料番号： W1266A ISSN： 1470-2045 資料種別：逐次刊行物 (A)
記事区分：原著論文発行国：オランダ (NLD) 言語：英語 (EN)

JDreamⅢ複写サービスとは

JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします

※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。

TOP

BOTTOM